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Abstract: In common with most viruses, measles virus (MV) relies on the integrity of the 
cytoskeleton of its host cells both with regard to efficient replication in these cells, but also 
retention of their motility  which  favors  viral dissemination. It is,  however,  the surface 
interaction of the viral glycoprotein (gp) complex with receptors present on lymphocytes 
and  dendritic  cells  (DCs),  that  signals  effective  initiation  of  host  cell  cytoskeletal 
dynamics. For DCs, these may act to regulate processes as diverse as viral uptake and 
sorting, but also the ability of these cells to successfully establish and maintain functional 
immune synapses (IS) with T cells. In T cells, MV signaling causes actin cytoskeletal 
paralysis associated with a loss of polarization, adhesion and motility, which has been 
linked  to  activation  of  sphingomyelinases  and  subsequent  accumulation  of  membrane 
ceramides. MV modulation of both DC and T cell cytoskeletal dynamics may be important 
for the understanding of MV immunosuppression at the cellular level.  
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1. Introduction  
Measles  virus  (MV)  is  the  type  species  of  the  genus  morbillivirus,  which  are  members  of  the 
paramyxoviridae. Its replication is confined to humans and—mainly experimentally—to non-human 
primates, while it is prevented in murine cells due to type I interferons and their effector proteins and 
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other unknown determinants [1]. In humans, the highly infectious MV causes a well known disease in 
unprotected  hosts,  usually  contracted  early  in  childhood,  which  is  self-limiting  and  leaves  the 
individual  with  a  life-long  protective  immunity.  Concurrent  with  efficient  virus-specific  immune 
activation, MV causes a generalized, transient immunosuppression allowing for secondary infections 
to occur and to follow a severe or even lethal course; thereby, constituting the major cause of measles 
associated infant mortality. Hallmarks of MV-induced immunosuppression are leukopenia affecting 
most, if not all, peripheral blood mononuclear cell compartments and the inability of lymphocytes to 
expand in response to activation ex vivo [2]. Because the frequency of MV-infected peripheral blood 
cells is very low (not exceeding 2% at any stage of the disease) [3,4], bystander effects of infected 
cells on uninfected cells are thought to be major components of lymphocyte inhibition. The model 
facets, which are investigated from different angles in many laboratories, predict that MV abrogates T 
cell activation at the level of antigen presenting cell (APC)/T cell communication, also including the 
ability of these cells to establish functional immune synapses (IS).  
2. The Role of the Cytoskeleton in MV Uptake and Replication 
For  host  entry,  MV  crosses  the  respiratory  epithelium,  and  for  this,  infects  tissue  resident 
professional  APCs  (e.g.,  dendritic  cells  (DCs)  or  macrophages)  rather  than  epithelial  cells. 
Subsequently, MV accesses secondary lymphatic tissues via infected APCs, where efficient replication 
along  with  transmission  to  lymphocytes  occurs,  essentially  enabling  viral  dissemination  to  the 
reticulo-endothelial  system  and  lymphatic  tissues  [3,5–7].  Tissue  distribution  in  the  hematopoietic 
system and pathogenesis of wild-type MV infection in vivo segregates well with the expression pattern 
of its entry receptor CD150 (also referred to as signaling lymphocyte activation molecule, SLAM), a 
member of the Ig family, which is confined to cells of the hematopoietic lineage [8,9]. Attenuated or 
laboratory adapted MV strains can additionally use CD46, a member of the complement regulator 
family, to which they bind with higher affinity in vitro [10,11]. To what extent interaction with this 
molecule, which is ubiquitously expressed on all nucleated human cells, determines tissue distribution 
in  vivo  has  not  yet  been  established.  CD150  and  CD46  also  recruit  signaling  complexes,  which 
regulate both activation of T cells and the polarity of the T cell response [8,12].  
In addition to these characterized entry receptors, wild-type MV interacts and can use other, as yet 
uncharacterized, receptors to enter endothelial, epithelial and neuronal cells [13–16], while molecules 
such as substance P receptor or moesin may aid rather than directly promote MV entry [17]. Obviously 
confined to APCs, DC-SIGN (DC-specific Intercellular adhesion molecule-3-Grabbing Non-integrin) 
interaction enhances, but does not mediate MV uptake into DCs, and signals in response to MV. This 
is also true for Toll like receptor 2 (TLR2) on monocytes and may play an important role in monocyte 
activation along with CD150 upregulation on these cells [18,19]. These interactions all involve the MV 
hemagglutinin (H) gp alone (for attachment) or in combination with the fusion (F) gp (for entry), 
which, together as the MV gp complex, also elicit signaling in lymphocytes in a contact dependent 
manner (see below). In addition, ligation of the Fc receptor on B cells and an unknown receptor on 
lymphocytes  by  the  MV  nucleocapsid  (N)  protein,  modulates  antibody  production,  viability  or 
proliferation of target cells (all summarized in Figure 1) [20,21].  Viruses 2011, 3                         
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Figure  1.  Cellular  surface  molecules  interacting  with  measles  virus  (MV).  Surface 
receptors may interact with different MV protein or protein complexes, yet only CD46 and 
CD150 support MV entry. This may be enhanced by substance P receptor interaction, and, 
on dendritic cells (DCs), by DC-SIGN which, as TLR2, promotes APC activation on MV 
binding  by  relaying  signals.  Signaling  by  CD46  and  CD150,  which  can  act  as  CD3  
co-stimulators, has mainly been investigated on antibody ligation and has not yet been 
directly addressed to occur after MV interaction. Signaling via recX and FcR by MV has 
been directly linked to inhibition of lympho/monocytic expansion and/or function.  
 
 
While  at  least  some  of  the  MV  receptor  interactions  outlined  above  were  clearly  linked  to 
modulation of cytoskeletal dynamics (which will be detailed below), little is generally known on the 
role of the cytoskeleton in MV uptake. The role of cytoskeletal dynamics in MV entry has not yet been 
analyzed.  It  is,  thus,  unknown  whether  MV  attachment  and  entry  involves  actin-dependent 
translocation of trapping molecules along filopodial structures as revealed for HIV, or if clustering of 
entry receptors (especially CD150, see below) might be required. The impact of actin depolymerizing 
compounds on viral entry has not been studied as yet. MV gp signaling causes moesin and cofilin 
dephosphorylation on binding to T lymphocytes [22], which promotes actin remodeling, and this has 
been suggested to enhance microtubule formation. This has been implicated to facilitate transport of 
lentiviral  cores  pseudotyped  with  MV  gps  towards  the  nucleus,  and  may  also  be  important  in 
trafficking of MV cores [23] (Figure 2). Whether this also refers to the intracellular transport of MV 
cores (which would then specifically apply to hematopoietic cells) has not been resolved.  
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Figure  2.  The  role  of  the  cytoskeleton  in  MV  replication.  Wild-type  MV  enters  into 
hematopoetic cells after binding to CD150 (or CD46, middle structure). Not yet shown to 
occur in response to MV interaction, CD46 and CD150 can activate actin remodeling, on 
ligation.  Similarly,  recX,  when  interacting  with  MV,  promotes  signals  causing 
dephosphorylation of ezrin-radixin-moesin (ERM) proteins and cofilin, and thereby actin 
remodeling  and  microtubule  formation  (both  in  blue).  Activation  of  cytoskeletal 
remodeling may facilitate MV entry and subsequent transport of MV cores (in brown) to 
perinuclear sites where MV replication occurs, which may rely on tubulin interaction of the 
replicase. Mechanisms of core transport towards the budding site are unclear, yet there is 
evidence that it involves vesicular trafficking pathways (sensitivity to Rab9 abrogation). 
The budding process itself is actin dependent, and barbed ends of actin filaments were 
detected in association with the nucleocapsid in budding virions by EM.  
 
 
Actin is packaged within MV virions, and suggesting a role of actin in virion formation, particle 
production is cytochalasin B and D sensitive [24,25]. As revealed at the ultrastructural level, MV 
budding  at  the  plasma  membrane  shares  similarities  to  generation  of  microvillar  protrusions  with 
regard to actin filament recruitment [26]. These observations corroborated earlier findings where the 
majority of MV structural proteins were found in association with the actin cytoskeleton in infected 
cells [27]. Interestingly, actin filaments were found to almost exclusively protrude with their barbed 
ends  into  virus  particles  in  close  association  with  the  nucleocapsids  indicating  that  MV  budding 
involves  vectorial  growth  of  actin  filaments.  In  vitro,  actin  was  found  associated  with  purified 
ribonucleoprotein  complexes  (RNPs),  yet  tubulin,  rather  than  actin,  co-precipitated  with  and  was Viruses 2011, 3                         
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required for the activity of the viral polymerase complex, indicating that cytoskeletal components are 
important at different steps of MV replication [28]. These observations were confirmed in studies in 
infected Vero cells, which did, however, not reveal targets in the MV replication cycle either [29]. 
Though likely to occur, microtubular trafficking of MV RNPs involving molecular motors such as 
dynein or kinesin within infected cells, especially neurons, has not yet been proven. Abrogation of MV 
release on Rab9 ablation from infected HeLa implies a role of vesicular trafficking pathway for the 
RNP [30,31] (Figure 2). Overall, the limited amount of data available suggest that, similar to that of 
related viruses (such as respiratory syncytial virus, RSV) [32], microtubules might play a dominant 
role in the formation and long distance transport of MV RNPs while actin plays a more prominent role 
in virus release.  
Given  the  importance  of  the  cytoskeleton  network  for  MV  replication  and  release,  it  is  not 
surprising that there is no evidence for disruption of the actin-, vimentin- or tubulin network in MV 
infected tissue culture cells [33]. Spatial alterations of cytoskeletal components such as intermediate 
and  thin  (actin)  filaments  observed  in  persistently  MV  infected  cells  were  interpreted  as  relating  
to  disturbances  of  RNP  transport  from  assembly  sites  to  the  plasma  cell  membrane,  and  thereby 
to persistency. 
Because MV infects and relies on motile cells for dissemination, MV infection per se, for obvious 
reasons,  does  not  grossly  perturb  cytoskeletal  dynamics  relating  to  the  morphological  front-rear 
polarization (including receptor segregation), acquisition of a motile phenotype and migration. In fact, 
MV infected DCs and lymphocytes were readily detectable in the majority of lymphoid compartments 
including the bone marrow in infected rhesus macaques [3,6]. In vitro, MV infection of immature DCs 
promoted  phenotypic  maturation  resembling  that  driven  by  TLR4  ligation,  and  also  enhanced 
Rac-dependent migration of these cells on fibronectin (FN) (mimicking extracellular matrix (ECM) 
interaction and 1-integrin ligation) [34]. Similarly, MV infection did not grossly affect chemokinesis 
of  lymphocytes  through  filters,  while  transendothelial  migration  of  these  cells  was  efficiently 
abrogated [35], which related to integrin upregulation and activation promoting lymphocyte retention 
rather than interference with cytoskeletal rearrangement.  
3. MV Interference with T Cell Signaling and Activation 
Cytoskeletal rearrangements essentially govern any step of the formation of an IS where recognition 
of its cognate peptide/major histocompatibility (MHC) complex on the APC by the T cell receptor 
(TCR) triggers T cell activation, expansion and finally, differentiation. IS formation is preceded by 
trapping of T cells on the APC surface, which is followed by ameboid T cell migration for scanning for 
cognate  MHC-peptide  complexes,  during  which  they  retain  their  polarized  morphology  and 
longitudinal protein gradients, and continuously reorganize their lamellopodia at the leading edge. On 
antigen recognition, large scale rearrangements of the T cell occur, involving adhesion strengthening 
by leucocyte function antigen 1 (LFA-1) activation and T cell re-polarization by the segregation of an 
enlarged, flattened interface with the APC, to which the microtubule organizing center (MTOC) is 
translocated as well, and, opposite, the distal pole complex [36–38]. Rearrangements of receptors and 
signaling  complexes  as  well  as  the  formation  of  localized  signaling  clusters  and  their  centripetal 
circulation  involves  actin  cytoskeletal  dynamics,  which  is  accompanied  by  rapid Viruses 2011, 3                         
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activation/de-activation  of  ezrin-radixin-moesin  (ERM)  proteins,  which  also  promote  cytoskeletal 
relaxation as important for conjugate formation [39,40]. In line with the importance of actin dynamics 
in  this  process,  latrunculin  terminates  T  cell  activation  as  determined  by  loss  of  tyrosine-
phosphorylation,  Ca-mobilization,  and  conjugate  stability,  within  less  than  two  minutes  [41].  In 
conjugates involving B cells as APCs, the IS acquires a typical ‘bull’s eye’ architecture where central, 
peripheral and distal supramolecular activation clusters (SMACs) containing CD3/CD28, LFA-1 or 
CD43, respectively, can be discerned (cSMAC, pSMAC, dSMAC). In contrast, IS involving DCs are 
predominantly multifocal in that multiple domains concentrating signaling clusters are separated by 
LFA-1 enriched protrusions, thereby segregating the actual signaling domains [41,42].  
Sustained  activation  of  tyrosine  kinases,  especially  Zeta-chain-associated  protein  kinase  70 
(ZAP-70) and lymphocyte-specific protein tyrosine kinase (Lck), and Ras activation are essential for 
calcium  mobilization  and  Nuclear  factor  of  activated  T-cells  (NFAT)  activation,  while  sustained 
activation of the phosphatidyl-inositol-3 kinase (PI3K) pathway provides membrane domains enriched 
for inositolpolyphosphates (phosphatidyl-inositol-3,4,5-phosphates, PIP3,4,5) which serve as docking 
sites  for  pleckstrin  homology  containing  proteins  such  as  the  Akt  kinase  and  major  guanosine 
exchange factors regulating the activity of small GTPases of the Rho family [41,43]. More recently, 
semaphorin receptors and their ligands, known to activate GTPases and essentially control adhesion or 
repulsion by targeting integrin activation and function, have also been implicated in IS function [44]. 
Within the following sections, we will review how MV might regulate T cell activation independently 
of infection by interacting with surface receptors.  
Signaling of MV Entry Receptors Independently of Infection 
As alluded to above, both CD46 and CD150 are signaling molecules with the property of shaping 
the quality of lymphocyte responses, which has been extensively studied and reviewed (examples are 
[8,9,12,45]). Interestingly, both molecules also act as phagocytic receptors with the capacity of routing 
their  cargo  into  degradative  phagosomal  compartments  and  to  recruit  autophagy-associated 
components  [46,47].  Most  likely,  MV  escapes  from  degradation  because  it  uses  these  molecules 
(CD150 alone for wild-type strains, or both for attenuated strains) not only for binding but also for 
help in membrane fusion.  
A  growing  number  of  pathogens,  also  including  human  herpesvirus  6,  adenovirus  and  certain 
Neisseria species, have chosen CD46, a non-raft molecule, as a receptor, and thus, consequences of 
ligation of this molecule on cellular functions has received much attention in the recent past [12]. 
CD46 acts to costimulate CD3 in primary human T cells to enhance activation of extracellular signal 
regulated kinase (ERK), but also to promote morphological alterations and actin relocalization towards 
the leading edge, compatible with front-rear polarization and acquisition of a motile phenotype [48]. 
Consistent with lamellopodia formation in these cells, CD46 ligation alone, and more pronounced on 
CD3 co-ligation, caused tyrosine phosphorylation of Vav and activation of the small GTPase Rac, yet 
not  RhoA  or  Cdc42  (Figure  2).  Obviously,  CD46  cytoplasmic  domain  isoforms  generated  due  to 
alternative splicing are differentially active in promoting Vav activation on ligation and this affected 
the  degree  of  morphological  alterations  and  substrate  or  homotypic  adhesion  [49].  Since  CD46 
dependent  regulation  of  cytoskeletal  activity  in  these  systems  by  antibodies  were  dependent  on Viruses 2011, 3                         
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crosslinking, it is likely that they would also occur on ligation by MV, which would, however, only 
refer to CD46 use and thereby attenuated strains. The same applies to a potential regulation of ERM 
protein  family  members  by  interaction  with  CD46.  There,  physical  and  functional  association  of 
moesin and CD46 in MV uptake were reported, yet the contribution of moesin in this process remained 
unclear and its activation status and association with the plasma cell membrane and actin cytoskeleton 
were  not  analyzed  [50].  Though  ERM  proteins  doubtlessly  play  an  important  role  in  cytoskeletal 
dynamics and receptor segregation in T cell activation [40,51], the importance of CD46 in regulating 
these molecules in this process in general or its role in modulation of T cell activation by wild-type 
MV has not yet been substantiated.  
As a member and type species of the SLAM family, CD150 (SLAMF1), apart from its role as 
receptor for MV and microbial sensor for certain gram-negative bacteria (see above), is a self ligand 
with a strong tendency for lateral self aggregation [8]. Specific adaptors (SLAM-associated protein 
(SAP) in T, NKT and some B cells, and Ewing Sarcoma Breakpoint region 1/Friend Leukemia Virus 
Integration-activated  transcript  2  (EAT-2)  in  NK  cells,  DCs  and  macrophages)  couple  CD150  to 
downstream signaling pathways, which also include recruitment of FynT but also p21 activated kinase 
(PAK) interacting exchange factor (PIX) [52]. This suggests that CD150 signaling could indeed, via 
PAK activation, regulate cytoskeletal dynamics (Figure 2). This has, however, so far not been directly 
revealed, nor has any impact of CD150 ligation on T cell morphing been noted. Not yet verified to 
occur in T cells as well, CD150 can, on coupling to the 5'lipid phosphatase SHIP-1 (SH2-containing 
inositol phosphatase-1), activate ERK, and, independently of tyrosine phosphorylation and SHIP-1 
recruitment, Akt phosphorylation in B cells [53]. On ligation by antibodies, CD150 potentiated or even 
induced—in the absence of concomitant TCR engagement—cytokine release from human T cells or 
promoted  cytotoxicity  of  CD8+  T  cells  collectively,  rendering  it  an  overall  efficient  T  cell 
co-stimulator. Consequences of MV ligation for CD150 signaling are as yet unknown.  
4.  MV  Surface  Interaction  with  T  Lymphocytes:  The  Cytoskeletal  Collapse  and  Role  of 
Sphingomyelinase Activation 
Almost 15 years ago it became clear that surface interaction with the MV gp complex abrogated 
stimulated or—in cell lines—constitutive proliferation of hematopoietic cells [54]. This did not involve 
CD150  or  CD46,  membrane  fusion,  infection,  apoptosis  or  release  of  soluble  inhibitory  factors.  
Rather, cells exposed to the MV gp complex on infected cells, cells transfected to express MV F/H 
proteins  or  inactivated  virions,  arrested  in  the  G1  phase  of  the  cell  cycle  associated  with  typical 
deregulation  of  cyclin  dependent  kinases  and  their  inhibitors,  provided  the  F  protein  was 
proteolytically  activated  [55–59].  Importantly,  the  MV  gp  complex  also  caused  similar  effects  in 
experimentally infected cotton rats [60,61].  
On  a  molecular  level,  MV  gp  signaling  was  found  to  target  activation  of  the  PI3/Akt  kinase 
pathway in response to IL-2R or TCR triggering [62] (Figure 3). Later, this was related to both delayed 
degradation of Cbl-b, or, generated by alternative splicing due to PI3K inhibition, a constitutively 
active SHIP-1 isoform, which continuously depleted the plasma membrane PIP3,4,5 pool thereby raising 
the threshold for activation [63,64]. Vav is a downstream effector of PI3K and, thus, MV signaling 
targeted  TCR-dependent  activation  of  Rac1  and  Cdc42,  yet  not  RhoA  which  was  even  slightly Viruses 2011, 3                         
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activated on MV exposure. Indicating that MV contact abrogated actin cytoskeleton reorganization, the 
ability of T cells to adhere to and polarize on FN or -CD3/CD28 coated substrates was strongly 
impaired as was their ability to translocate the MTOC towards the IS and CD3 to the cSMAC in 
conjugates with lipopolysaccharide(LPS)-matured DCs [22].  
More  recently,  we  were  able  to  show  that  TCR-mediated  IS  recruitment  of  plexinA1  and 
neuropilin-1, a semaphorin receptor complex, which is involved in early IS formation and function, is 
also ablated in MV exposed T cells [65–67]. As evidenced in neuronal cells, translocation of these 
molecules and the activity of the signaling moiety, plexinA1, to regulate adhesion, involve cytoskeletal 
dynamics  and  integrin  signaling,  respectively  [68].  PlexinA1/neuropilin-1  are  expressed  both  on  
T  cells  and  DCs,  and  thus,  their  effect  to  promote  early  IS  functions  may  involve  homotypic 
interaction, though heterotypic have not been excluded. Late after DC activation, soluble semaphorin 
3A  (SEMA3A)  is  produced,  which  acts  as  a  repulsive  ligand  promoting  collapse  of  actin  based 
structures,  e.g.,  in  neuronal  growth  cones,  and  this  involves  adaptor  proteins  also  referred  to  as 
‘collapsins’ [69,70]. In line with its function in resolving cell contacts, SEMA3A production late after 
DC/T cell interaction has been related to termination of activation [71,72], and it is thus remarkable 
that  in  co-cultures  of  MV-infected  DCs  and  T  cells,  this  repulsive  semaphorin  receptor  ligand  is 
produced already within the first hours. Recombinant SEMA3A (and SEMA6A) caused a marked 
transient loss of cellular actin and actin based protrusions, yet only moderately affected DC/T cell 
conjugate stability and efficiency in vitro [67,72], and thus, the role in regulating IS functions and 
potential  modulations  thereof  by  viruses  remains  to  be  established.  Semaphorin  production  may, 
however, not essentially contribute to the instability of conjugates formed between MV-infected DCs 
and T cells. The majority of conjugates observed in these co-cultures resolved within less than two 
minutes  and  only  allowed  for  a  transient  Ca-burst  instead  of  sustaining  both  the  cell  contact  and  
Ca-mobilization  as  required  for  T  cell  activation.  Indicating  that  again  the  MV  gp  complexes 
essentially  accounted  for  loss  of  IS  stability,  this  was  largely  rescued  when  DCs  infected  with  a 
recombinant MV expressing VSV G protein instead were used in conjugate formation [34].  
MV exposure does not only affect stimulated cytoskeletal rearrangements, yet causes a loss of actin 
based  microvillar  structures  from  T  cells,  and  this  was  accompanied  by  a  loss  of  ERM  protein 
phosphorylation  [22]  (Figure  3).  These  observations,  together  with  RhoA  activation  and  PI3K 
interference (see above) were consistent with those made mainly in non-T cells after activation of 
spingomyelinases (SMases). These differ in their respective pH optimum, and their activity largely 
accounts  for  accumulation  of  membrane  ceramides;  that  of  the  acid  sphingomyelinase  (ASM) 
catalyzes  the  transformation  of  small  membrane  cholesterol  and  sphingomyelin  (SM)  enriched 
microdomains (also referred to as rafts) into large, ceramide-enriched membrane platforms in response 
to a variety of external stimuli [73,74]. In hematopoietic cells, these include ligation of death receptors 
CD40, FcRII and CD28 [75,76]. Pathogens such as P. aeruginosa, S. aureus and rhinovirus promote 
and  rely  on  formation  of  ceramide-enriched  platforms  for  entry  (reviewed  in  [75])  while 
fusion-dependent uptake of HIV is prevented on ceramide accumulation [77,78]. Ceramide enriched 
platforms  regulate  lateral  diffusion  and  recruitment  of  surface  receptors  and  membrane-proximal 
signaling  complexes,  thereby  enhancing  initiation  or  modulating  signaling  pathways  including 
PI3K [79,80].  SMase  activation  was  also  implicated  in  cytoskeletal  remodeling  in  breast  cancer  
MCF-7  cells  [81,82].  There,  cisplatin  induced  ASM  activation  and  subsequent  sphingomyelin Viruses 2011, 3                         
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breakdown in the outer membrane bilayer promoted a protein phosphatase 2A (PP2A)-dependent loss 
of ERM protein phosphorylation and of actin based protrusions.  
Figure  3.  MV  signaling  via  receptorX  causes  T  cell  actin  cytoskeletal  paralysis.  On 
binding  to  recX,  the  MV  gp  complex  (consisting  of  the  proteolytically  activated  F1/2 
heterodimer and the H protein) signals to abrogate PI3K activation, e.g., in response to 
TCR ligation (CD3/CD28), which causes inactivation of downstream effectors such as Akt 
kinase,  Vav  and  Rac1/Cdc42.  To  a  major  extent,  PI3K  interference  is  mediated  by 
sequential activation of neutral (NSM) and acid sphingomyelinase (ASM), which promotes 
surface  translocation  of  ASM  and  subsequent  breakdown  of  outer  membrane 
sphingomyelin (SM) and formation of ceramide (Cer)-enriched membrane microdomains. 
ASM  activation  and  ceramide  accumulation  have  been  linked  to  abrogation  of  ERM 
phosphorylation,  RhoA  activation  and  PI3K  interference  and  loss  of  actin  based 
protrusions in non-lymphoid cells. In T cells, ceramide induction by MV or recombinant 
bacterial sphingomyelinase has been directly linked to the MV (bottom panels) loss of actin 
cytoskeletal dynamics as evidenced by loss of actin and receptor polarization, microvillar 
protrusions  or  lamellopodial  structures  on  substrates  mimicking  the  ECM  (such  as 
fibronectin, bottom right panels, where actin is detected by phalloidin (green), the arrow 
marks  the  leading  edge  in  MOCK  treated  cells)  or  the  immunological  synapse 
(CD3/CD28  coated  slides,  bottom  left  panels;  the  upper  panel  shows  two  interacting 
MOCK  treated  T  cells).  Whether  ceramide  accumulation  also  directly  accounts  for 
MV-dependent inhibition of IS formation or T cell activation is as yet unknown (therefore 
indicated in italics).  
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Indeed,  MV  exposure  was  found  to  sequentially  activate  NSM  and  ASM  in  T  cells,  and  this 
accounted for the general loss of actin cytoskeletal dynamics in these cells  [83] (Figure 3). Thus, 
pharmacological or genetic ablation of SMase activation essentially restored the ability of MV exposed 
T cells to polarize and spread on substrates, segregate receptors, migrate in response to stromal cell 
derived factor 1 (SDF-1) and to retain actin-based microvillar protrusions. In turn, exogenous ceramide 
accumulation  caused  loss  of  polarity  and  ezrin,  yet  not  moesin  phosphorylation  on  stimulation 
indicating  that  SMAse  activation  in  general  acts  to  regulate  T  cell  activation  by  modulating 
cytoskeletal dynamics.  
5. Outlook: SMase Activation in Immune Cells—Is There More to It? 
As  outlined  above,  SMase  activation  in  response  to  receptor  triggering  may  promote  receptor 
clustering favoring subsequent internalization [73,75]. Because lateral concentration of viral receptors 
has  been  proposed  to  be  one  of  the  principles  underlying  enhancement  of  viral  DC  infection  by 
DC-SIGN [84], we addressed the possibility that SMase activation could play a role in this process. 
Indeed, ligation of DC-SIGN by antibodies, mannan or MV caused activation of both NSM and ASM 
within few minutes and subsequent outer membrane display of ceramides [85]. SMase activation was 
found to be essential for membrane proximal relay of DC-SIGN signaling as reflected by abrogation of 
Raf-1 and ERK-1/2 phosphorylation known to occur in response to DC-SIGN ligation [86–88] by 
SMase inhibitors, but also for promoting enhancement of MV uptake into DCs. This was linked to 
SMase-dependent  translocation  of  CD150  from  intracellular  storage  compartments  for  transient 
membrane display [85]. Though not analyzed to occur in DCs, HIV fusion mediated uptake was found 
to be inhibited rather than enhanced by accumulation of membrane ceramides because this interfered 
with lateral CD4/chemokine receptor co-segregation [77,78,89]. It is tempting to speculate that—in 
case HIV would also cause DC-SIGN dependent SMase activation there—lateral segregation of its 
entry receptors on DCs might favor enhancement of internalization and storage of viral particles for 
subsequent trans-infection of T cells. Thus, SMase activation by attachment receptor interaction might 
be highly relevant for the mode of viral uptake into DCs and subsequent delivery to T cells and thereby 
viral pathogenesis. 
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